Background: The glucose transporter protein 1 (Glut-1) overexpression is associated with poor overall survival (OS) in various malignant tumors. The aim of this study was to investigate prognostic significance of Glut-1 overexpression in patients with bone and soft-tissue sarcomas.

Methods: A total of 67 patients (mean age, 43 years; range, 8-79 years) with bone and soft tissue sarcomas were analyzed. Pathologic confirmation was observed from surgical specimens in all patients. Pathologic variables including tumor differentiation, necrosis, mitotic index, MIB-1 (Ki-67) grade and Glut-1 expression were assessed. Clinical characteristics and pathologic variables were determined by Kaplan-Meyer curve of OS after treatment.

Results: Glut-1 overexpression was found in 56 patients (83%). The patients with Glut-1 overexpression showed significantly poor OS compared with those without Glut-1 overexpression (P = 0.029). The presence of metastasis, treatment without surgical resection, tumor differentiation, necrosis, mitotic index and MIB-1 grade were also significantly negative prognostic factors. The presence of metastasis was independently associated with poor OS (P = 0.031).

Conclusions: Assessment of Glut-1 expression prior to treatment has a predictive potential effect in patients with bone and soft-tissue sarcomas.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hym125DOI Listing

Publication Analysis

Top Keywords

glut-1 overexpression
24
bone soft-tissue
12
glucose transporter
8
glut-1
8
soft-tissue sarcomas
8
associated poor
8
overexpression patients
8
patients bone
8
pathologic variables
8
tumor differentiation
8

Similar Publications

Background: Glaucoma is a group of heterogeneous neurodegenerative diseases with abnormal energy metabolism and imbalanced neuroinflammation in the retina. Thioredoxin-interacting protein (TXNIP) is involved in glucose and lipid metabolism, and associated with oxidative stress and inflammation, however, not known whether to be involved in glaucoma neuropathy and its underlying mechanisms.

Methods: To establish the chronic ocular hypertension (COH) mice model.

View Article and Find Full Text PDF

Hypoxia-inducible factor-1 (HIF-1) regulates cell growth, protein translation, metabolic pathways and therefore, has been advocated as a promising biological target for the therapeutic interventions against cancer. In general, hyperactivation of HIF-1 in cancer has been associated with increases in the expression of glucose transporter type-1 (GLUT-1) thus, enhancing glucose consumption and hyperactivating metabolic pathways. The collective behavior of GLUT-1 along with previously known key players AKT, OGT, and VEGF is not fully characterized and lacks clarity of how glucose uptake through this pathway (HIF-1) probes the cancer progression.

View Article and Find Full Text PDF

Malignant fibroblasts (MFs) are widely present in various diseases and are characterized by connective tissue proliferation; these cells act as a physical barrier that severely limits drug delivery and affects disease outcomes. Based on this, we constructed the smart, integrated, theranostic, targeted lipid nanoprobe HMME-RG3@PFH to overcome the bottleneck in the early diagnosis and treatment of MF-related diseases. The protein glucose transporter protein 1 (GLUT-1) is overexpressed on MFs, and its ideal substrate, ginsenoside RG3 (RG3), significantly enhances the targeted uptake of HMME-RG3@PFH by MFs in a hypoxic environment and endows the nanomaterial with stealthiness to prolong its circulation.

View Article and Find Full Text PDF
Article Synopsis
  • - This study evaluated the expression of glucose transporter (GLUT)-1 and hexokinase (HK)-II in vocal cord leukoplakia (VCL) and explored its clinical importance using samples from various throat conditions over a four-year period.
  • - Results showed significant differences in factors like sex and smoking between VCL and vocal cord polyp patients, with GLUT-1 and HK-II expressions being higher in laryngeal carcinoma cases, particularly in severe dysplasia.
  • - Both GLUT-1 and HK-II levels increased with the severity of dysplasia, indicating that their expression could serve as biomarkers for assessing the progression of VCL and its potential transformation to cancer.
View Article and Find Full Text PDF

The presence of cancer-associated fibroblast in breast cavity side margins is in correlation with the expression of oncoproteins by adjacent epithelial cells: a new era in cancerous potential.

J Cancer Res Clin Oncol

September 2024

Nano Bio Electronic Devices Lab, Cancer Electronics Research Group, School of Electrical and Computer Engineering, College of Engineering, University of Tehran, P.O. Box 14395/515, Tehran, Iran.

Article Synopsis
  • Cancer-associated fibroblasts (CAFs) play a vital role in tumor progression and can transform adjacent normal tissue into a neoplastic state due to oxidative stress pathways, affecting breast cancer margins.
  • The study used advanced biosensors to analyze the glycolytic behavior of non-tumoral margins and detect CAF accumulation, investigating the relationship between CAF presence and the neoplastic potential in surrounding tissues.
  • Results showed significant increases in specific cancer-associated transcripts in glycolytic but histologically non-cancerous areas, indicating that these areas may still harbor high-risk cells influenced by CAF activity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!